The largest database of trusted experimental protocols

31 protocols using microparticle enzyme immunoassay

1

Metabolic Biomarker Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma insulin was measured using an Abbott AxSYM system (Abbott Laboratories, Abbott Park, IL, USA) by microparticle enzyme immunoassay (Abbott Diagnostics, Wiesbaden, Germany) with an inter-assay coefficient of variation (CV) of <5%. Glucose, triglyceride, total cholesterol, HDL-C, and LDL-C concentrations were measured on a Hitachi 902 autoanalyser (Hitachi High Technologies Corporation, Tokyo, Japan) by enzymatic colorimetric assay (Roche, Mannheim, Germany) with an inter-assay CV of 1.2% for glucose, and <5% for the other parameters.
+ Open protocol
+ Expand
2

Measurement of Lipid and Inflammatory Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood from the participants was collected in tubes containing EDTA after a 12-h overnight fast. Lipid variables were assessed with the modular auto analyzer DDPPII Hitachi (Roche, Basel, Switzerland) using specific reagents (Boehringer-Mannheim, Mannheim, Germany). Measurements of total cholesterol (TC) and triglycerides (TG) levels were made by colorimetric enzymatic methods25 (link),26 (link); high-density lipoprotein-cholesterol (HDL-c) levels were measured by colorimetric assay27 (link); and low-density lipoprotein (LDL-C) concentrations were calculated by the Friedewald equation, using the following formula: LDL-C = CT - (HDL-C + TG/5). Glucose measurements were performed using the hexokinase method. hs-C-reactive protein (hs-CRP) concentration was determined by high-sensitivity ELISA (BioCheck, Inc., Foster City, CA, USA). Plasma insulin concentrations were measured by microparticle enzyme immunoassay (Abbott Diagnostics, Matsudo-shi, Japan). Non-esterified fatty acid concentrations were measured by enzymatic colorimetric assay (Roche Diagnostics, Penzberg, Germany). ApoA-1 and ApoB concentrations were determined by immunoturbidimetry.
+ Open protocol
+ Expand
3

Lipid and Glucose Metabolism Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood from the participants was collected in tubes containing EDTA after a 12-hr overnight fast. Lipid variables were assessed with the DDPPII Hitachi modular auto analyzer (Roche, Basel, Switzerland) using specific reagents (Boehringer-Mannheim, Mannheim, Germany). Measurements of total cholesterol (TC) and TG levels were performed by colorimetric enzymatic methods,44 (link), 45 (link) c-HDL was measured by colorimetric assay,46 (link) and low-density lipoprotein (c-LDL) concentration was calculated by the Friedewald equation, using the following formula: c-LDL = CT − (c-HDL + TG/5). Glucose measurements were performed using the hexokinase method. The hs-C-Reactive Protein (hs-CRP) was determined by high-sensitivity ELISA (BioCheck, Foster City, CA, USA). Plasma insulin concentrations were measured by microparticle enzyme immunoassay (Abbott Diagnostics, Matsudo-shi, Japan). Non-esterified fatty acid concentrations were measured by enzymatic colorimetric assay (Roche Diagnostics, Penzberg, Germany). ApoA-1 and ApoB concentrations were determined by immunoturbidimetry.
+ Open protocol
+ Expand
4

Biomarkers for Atherothrombotic Risk Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was drawn after a 12-hour fast into EDTA tubes, and plasma samples were stored in freezers at -70°C until analysis. D-dimer levels (nanograms per milliliter) were measured at randomization and at 1 year by microparticle enzyme immunoassay (Abbott Diagnostics) in the MORGAM (MONICA [Multinational Monitoring of Trends and Determinants in Cardiovascular Disease], Risk, Genetics, Archiving, and Monograph) biomarker laboratory. 11 (link) Additional biomarkers in stored plasma samples were chosen to reflect the range of pathobiological processes considered important in the development of atherothrombotic disease: B-type natriuretic peptide (BNP; hemodynamic), sensitive troponin I (myocardial micronecrosis), cystatin C (renal function), high-sensitivity C-reactive protein (hs-CRP; inflammation), lipoprotein-associated phospholipase A 2 activity (inflammation), midregional proadrenomedullin
+ Open protocol
+ Expand
5

Hepatitis B Serology and Biomarker Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
All serum samples were assessed in each local clinical center laboratory with a standard procedure. Serum HBV surface antigen (HBsAg), HBV surface antibody (HBsAb), HBeAg, HBV e antibody (HBeAb), and HBV core antibody (HBcAb) were measured using microparticle enzyme immunoassay (Abbott Architect, North Chicago, IL). Serum HBV DNA levels were measured using a COBAS TaqMan PCR assay with a lower limit of detection of 20 IU/mL (Roche, Branchburg, NJ). The calculation of FIB-4, APRI, and eGFR were based on the literature.[22 (link),23 (link),24 (link)]
+ Open protocol
+ Expand
6

Fasting Biomarkers and Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasting levels of plasma glucose, insulin, and blood lipids were measured using standard laboratory methods (Department of Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden). LDL cholesterol was calculated using the Friedewald equation [19 (link)]. HbA1c was determined using high-performance liquid chromatography (Mono-S method). In this study, all HbA1c values were converted to International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) standard levels using the formula: HbA1c (IFCC) = (10.45 × HbA1c (Mono-S) -10.62 [20 (link)]. Plasma insulin was measured at the University of Tübingen, Germany, by micro-particle enzyme immunoassay (Abbott Laboratories, Tokyo, Japan).
Total circulating serum adiponectin concentrations were measured by an ultrasensitive ELISA (B-Bridge, Sunnyvale, CA). Plasma IL-6 levels were quantified using an IL-6 specific proliferation bioassay. IL-6 concentrations were calculated using dilutions of recombinant human IL-6 (Genzyme, Cambridge, Massachusetts, USA) as previously described [21 (link)].
+ Open protocol
+ Expand
7

Hepatitis B Serological Markers Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Biochemistry was performed using standard laboratory procedures. Hepatitis B surface antigen (HBsAg), antibody to HBsAg (anti-HBs), HBeAg, and antibody to HBeAg (anti-HBe) were measured using microparticle enzyme immunoassay (Abbott Laboratories, North Chicago, IL, USA). Serum HBV DNA levels were measured using a COBAS TaqMan PCR assay (Roche, Branchburg, NJ, USA; lower limit of detection 20 IU/mL).
+ Open protocol
+ Expand
8

Hepatitis B Serology Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
All serum samples from 210 children were measured for HBsAg and anti-HBc using commercially available ELISA kits (Huakang Biotech, Shenzhen; Kehua Bio-Engineering, Shanghai, China), and were quantitatively tested for antibodies against HBsAg (anti-HBs) with microparticle enzyme immunoassay (Architect system, Abbott, North Chicago), with positive ≥10 mIU/ml. When HBsAg was positive, the sample was further quantitatively tested for HBsAg, HBeAg, and anti-HBc with microparticle enzyme immunoassay (Architect system, Abbott).
+ Open protocol
+ Expand
9

Fasting Insulin and Glucose Measurements

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasting insulin and glucose were measured at the first clinical visit. Fasting insulin (uIU/mL) was measured via Microparticle Enzyme Immunoassay; Abbott Laboratories Diagnostics Division, South Pasadena, CA. Fasting glucose (mg/dL) was measured using Vitros Glucose; Johnson & Johnson; Rochester, NY USA.
+ Open protocol
+ Expand
10

Cross-Sectional Study of Malaria, Anemia, and Hepcidin in Gambian Children

Check if the same lab product or an alternative is used in the 5 most similar protocols
All children aged 2–6 years old were recruited from ten rural villages in the West Kiang region of The Gambia during the malaria season (July to August 2001)42 (link). We used cross-sectional data collected at the start of the malaria season. All children had a clinical examination, anthropometric measurements and a 3-d course of mebendazole for possible hookworm infection. A blood sample was collected for complete blood count, observations with a malaria slide, measurements of ferritin (Microparticle Enzyme Immunoassay (Abbott Architect)), hepcidin (Hepcidin-25 (human) EIA Kit (Bachem) and ACT (immunoturbidimetry, Cobas Mira Plus Bio-analyzer, Roche) levels and DNA extraction. Children with a temperature >37.5°C had a malaria blood film, appropriate clinical treatment and a blood sample 2 weeks later after recovery from illness. Genotyping of sickle cell was performed on amplified DNA as detailed elsewhere42 (link). The Gambian Bachem hepcidin values were harmonized by converting to the old DRG hepcidin assay values ((0.266×Bachem values)+1.633) and then to the new High Sensitive DRG hepcidin assay values ((1.989× old DRG values)-3.24) as previously validated43 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!